Effects of creatine and cyclocreatine supplementation on kainate induced injury in pre-pubescent rats

Brain Injury

Volumn 18, Issue 12, 2004, Pages 1229-1241

  Mikati, Mohamad A ^a   Kurdi, Rana M ^a   Rahmeh, Amal A ^a   Farhat, Firas ^a   Rialy, Suha Abu ^a   Lteif, Lina ^a   Francis, Elie ^a   Geha, George ^a   Maraashli, Wael ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; CYCLOCREATINE; KAINIC ACID; PHENOBARBITAL; SODIUM CHLORIDE;

ADOLESCENT; AGGRESSIVENESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DEPTH PERCEPTION; DIET SUPPLEMENTATION; EMOTIONALITY; EPILEPTIC STATE; HIPPOCAMPUS; LEARNING DISORDER; MALE; MAZE TEST; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PREPUBERTY; RAT; SEIZURE;

EID: 8644224288     PISSN: 02699052     EISSN: None     Source Type: Journal    
DOI: 10.1080/02699050410001719880     Document Type: Article

References (44)

1. Stafstrom, C. E., Chronopoulos, A., Thurber, S. et al.: Age dependent cognitive behavioral deficits after kainic acid seizures. Epilepsia, 34: 420-432, 1993.
2. Mikati, M. A., Tarif, S., Lteif, L. et al.: Time sequence and types of memory deficits after experimental status epilepticus. Epilepsy Research, 43: 97-101, 2001.
3. Mikati, M. A., Holmes, G. L., Chronopoulos, A. et al.: Phenobarbital modifies seizure-related brain injury in the developing brain. Annals of Neurology, 36: 425-433, 1994.
4. Bolanos, A. R., Sarkisian, M., Yang, Y. et al.: Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology, 51: 41-48, 1998.
5. De France, J. F. and McCandless, D. W.: Energy metabolism in rat hippocampus during and following seizure activity. Metabolic Brain Disease, 6: 83-91, 1991.
6. Folbergrova, J.: Cerebral energy state of neonatal rats during seizures induced by homocysteine. Physiology Research, 42 155-160, 1993.
7. Sutherland, G. R., Ross, B. D., Lesiuk, H. et al.: Phosphate energy metabolism during domoic acid-induced seizures. Epilepsia, 34: 996-1002, 1993.
8. Holtzman, D., Mulkern, R., Meyers, R. et al.: In vivo phosphocreatine and ATP in piglet cerebral gray and white matter during seizures. Brain Research, 783: 19-27, 1998.
9. Holmes, G. L.: The long-term effects of seizures on the developing brain: clinical and laboratory issues. Brain Development 13: 393-409, 1991.
10. Weiser, H. G.: Temporal lobe epilepsies. In: P. J. Vinken, G. W. Bruyn and H. Meinardi (editors) Handbook of Clinical Neurology, Vol. 73, The epilepsies, Part II (Amsterdam: Elsevier Science), Ch 3, pp. 53-96, 2000.
11. Wallimann, T., Wyss, M., Brdiczka, D. et al.: Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochemistry Journal, 281: 21-40, 1992.
12. Lillie, J. W., O'keefe, M., Valinski, H. et al.: Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors. Cancer Research, 53: 3172-3178, 1993.
13. Teicher, B. A., Menon, K., Northey, D. et al.: Cyclocreatine in cancer chemotherapy. Cancer Chemotherapy Pharmacology 35: 411-416, 1995.
14. Holtzman, D., Khait, I., Mulkern, R. et al.: In vivo development of brain phosphocreatine in normal and creatine treated rabbit pups. Journal of Neurochemistry, 73: 2477-2484, 1999.
15. Wyss, M. and Kaddurah-Daouk, R.: Creatine and creatinine metabolism. Phsiology Review, 80: 1107-1213, 2000.
16. Tarnopolsky, M. A. and Beal, M. F.: Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Annals of Neurology, 49: 561-574, 2001.
17. Lawler, J. M., Barnes, W. S., Wu, G. et al.: Direct antioxidant properties of creatine. Biochemistry and Biophysics Research Communications, 290: 47-52, 2002.
18. Matthews, R. T., Yang, L., Jenkins, B. G. et al.: Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. Journal of Neuroscience, 18: 156-163, 1998.
19. Matthews, R. T., Ferrante, R. J., Klivenyi, P. et al.: Creatine and cyclocreatine attenuate MPTP neurotoxicity. Experimental Neurology, 157: 142-149, 1999.
20. Klivenyi, P., Ferrante, R. J., Matthews, R. T. et al.: Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Natural Medicine, 5: 347-350, 1999.
21. Ferrante, R. J., Andreassen, O. A., Jenkins, B. G. et al. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. Journal of Neuroscience, 20: 4389-4397, 2000.
22. Malcon, C., Kaddurah-Daouk, R. and Beal, M. F.: Neuroprotective effects of creatine administration against NMDA and malonate toxicity. Brain Research, 860: 195-198, 2000.
23. Horn, M., Frantz, S., Remkes, H. et al.: Effects of chronic dietary creatine feeding on cardiac energy metabolism and on creatine content in heart, skeletal muscle, brain, liver and kidney. Journal of Molecular Cell Cardiology, 30: 277-284, 1998.
24. Morris, R. G., Hagan, J. J. and Rawlins, J. N.: Allocentric spatial learning by hippocampectomised rats: a further test of the 'spatial mapping' and 'working memory' theories of hippocampal function. Quarterly Journal of Experimental Psychology B, 38: 365-395, 1986.
25. Nadler, J. V.: Minireview: kainic acid as a tool for the study of temporal lobe epilepsy. Life Science, 29: 2031-2042, 1981.
26. Ben-Ari, Y.: Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience, 14: 375-403, 1985.
27. Kekelidze, T., Khait, I., Togliatti, A. et al.: Brain creatine kinase and creatine transporter protiens in normal and creatine-treated rabbit pups. Developmental Neuroscience, 22: 437-443, 2000.
28. Meldrum, B. S.: Metabolic factors during prolonged seizures and their relation to nerve cell death. Advances in Neurology, 34: 261-275, 1983.
29. Kreisman, N. R., Rosenthal, M., LaMnana, J. C. et al.: Cerebral oxygenation during recurrent seizures. Advances in Neurology 34: 231-239, 1983.
30. Howse, D. C.: Cerebral energy metabolism during experimental status epilepticus. Advances in Neurology, 34: 209-216, 1983.
31. Delgado-Escueta, A. V., Ward, A. A., Woodbury, D. M. et al.: New wave of research in the epilepsies. Advances in Neurology 44: 3-55, 1986.
32. Siesjo, B. K. and Wieloch, T.: Epileptic brain damage: pathophysiology and neurochemical pathology. Advances in Neurology, 44: 813-847, 1986.
33. Olney, J. W., Collins, R. C. and Sloviter, R. S.: Excitotoxic mechanisms of epileptic brain damage. Advances in Neurology, 44 857-877, 1986.
34. Gupta, R. C., Milatovic, D., Zivin, M. et al.: Seizure-induced changes in energy metabolites and effects of N-tert-butyl-alpha-phenylnitrone (PNB) and vitamin E in rats. Pflugers Archives, 440(suppl 5): R160-162, 2000.
35. Gupta, R. C., Milatovic, D. and Dettbarn, W. D.: Depletion of energy metabolites following acetylcholinesterase inhibitor-induced status epilepticus: protection by antioxidants. Neuro Toxicology, 22: 271-282, 2001.
36. Milatovic, D., Zivin, M., Gupta, R. C. et al.: Alterations in cytochrome c oxidase activity and energy metabolites in response to kainic acid-induced status epilepticus. Brain Res, 912: 67-78, 2001.
37. Meric, Ph., Barrere, B., Peres, M. et al.: Effects of kainate-induced seizures on cerebral metabolism: a combined 1H and 31P NMR study in rats. Brain Research, 638: 53-60, 1994.
38. Mikati, M. A., Abu Rialy, S., Lteif, L. et al.: Neuroprotective effects of phosphagens in the kainic acid model. Epilepsia, 39(suppl 6): 233-234, 1998. Abstract.
39. Ara, G., Gravelin, L. M., Kaddurah-Daouk, R. et al.: Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism. In Vivo, 12: 223-231, 1998.
40. Schiffenbauer, Y. S., Meir, G., Cohn, M. et al.: Cyclocreatine transport and cytotoxicity in rat glioma and human ovarian carcinoma cells: 31P-NMR spectroscopy. American Journal of Physiology 270: C160-169, 1996.
41. Holtzman, D., Togliatti, A., Khait, I. et al.: Creatine increases survival and suppresses seizures in the hypoxic immature rat. Pediatric Research, 44: 410-414, 1998.
42. Balestrino, M., Rebaudo, R. and Lunardi, G.: Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship. Brain Research, 816: 124-130, 1999.
43. Sullivan, P. G., Geiger, J. D., Mattson, M. P. et al.: Dietary supplement creatine protects against traumatic brain injury. Annals of Neurology, 48: 723-729, 2000.
44. Brewer, G. J. and Wallimann, T. W.: Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. Journal of Neurochemistry, 74: 1968-1978, 2000.